I find it incredible that we are below the SP (without a great deal of dilution in between) that we were post results of the P2 pediatric trial.
Think of the progress (without any regress) since then. The Lanstead funding, FDA approval, under favourable conditions, for the P3 and now a deal to fund that trial, with significant upside if successful plus funds to pursue 2591 development.
Crazy.
Mass Exodus, page-50
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.60 |
Change
0.000(0.00%) |
Mkt cap ! $1.995B | |||
| Open | High | Low | Value | Volume |
| $15.64 | $15.93 | $15.44 | $6.543M | 418.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 768 | $16.77 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.04 | 875 | 1 |
View Market Depth
| Last trade - 15.59pm 15/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |